Update on Drug-Eluting Stents
- 1 November 2007
- journal article
- review article
- Published by Wolters Kluwer Health in Dimensions of Critical Care Nursing
- Vol. 26 (6) , 237-240
Abstract
Coronary artery disease is the number 1 killer of Americans. There are many efforts underway to prevent and treat this life-threatening disease. One such treatment is the placement of drug-eluting stents. However, recent reports that show an increased risk of potentially life-threatening complications associated with drug-eluting stents have surfaced. This article provides a brief overview of research performed concerning the risks of drug-eluting stents.Keywords
This publication has 10 references indexed in Scilit:
- Unanswered Questions — Drug-Eluting Stents and the Risk of Late ThrombosisNew England Journal of Medicine, 2007
- Stent Thrombosis Redux — The FDA PerspectiveNew England Journal of Medicine, 2007
- Stent Thrombosis in Randomized Clinical Trials of Drug-Eluting StentsNew England Journal of Medicine, 2007
- Analysis of 14 Trials Comparing Sirolimus-Eluting Stents with Bare-Metal StentsNew England Journal of Medicine, 2007
- Safety and Efficacy of Sirolimus- and Paclitaxel-Eluting Coronary StentsNew England Journal of Medicine, 2007
- Drug-Eluting Coronary Stents — Promise and UncertaintyNew England Journal of Medicine, 2007
- Premature discontinuation of antiplatelet therapy in patients with drug-eluting coronary stentsAmerican Journal of Health-System Pharmacy, 2006
- Two‐Year Follow‐up of Sirolimus‐Eluting Stents for the Treatment of Proximal Left Anterior Descending Coronary Artery StenosisJournal of Interventional Cardiology, 2006
- Open new care pathways with drug-eluting stentsNursing Management, 2006
- Paclitaxel-eluting stents in coronary artery diseaseAmerican Journal of Health-System Pharmacy, 2005